Nebula Research & Development LLC Atri Cure, Inc. Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
A detailed history of Nebula Research & Development LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 27,066 shares of ATRC stock, worth $831,467. This represents 0.09% of its overall portfolio holdings.
Number of Shares
27,066
Previous 54,367
50.22%
Holding current value
$831,467
Previous $1.24 Billion
38.69%
% of portfolio
0.09%
Previous 0.2%
Shares
3 transactions
Others Institutions Holding ATRC
# of Institutions
212Shares Held
49.7MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$143 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$142 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$122 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$87 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$85.7 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.43B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...